FULL PAPERS
Synthesis of Sterically Congested Polycyclic Aromatic Hydrocarbons
126.3, 125.9, 125.3, 125.2, 125.0, 124.7, 124.4, 124.1, 123.5,
123.2, 34.2, 30.8, 23.3; HR-MS (EI-TOF): m/z=675.2932,
calcd. for C52H37N (M+): 675.2926.
1-Methyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-yl)-
ACHTUNGTRENNUNGisoquinoline (3b): obtained as a white solid according to the
(s, 3H), 2.35 (s, 3H); 13C NMR (100 MHz, CDCl3): d=
155.8, 151.8, 140.9, 140.8, 140.0, 139.3, 138.3, 138.1, 137.8,
137.6, 135.4, 133.4, 133.3, 132.2, 131.5, 131.4, 131.2, 131.0,
130.4, 130.3, 128.9, 128.2, 127.8, 127.3, 127.1, 127.0, 126.6,
126.5, 126.4, 126.2, 125.9, 125.4, 125.2, 125.0, 124.8, 124.7,
124.4, 124.2, 22.2, 22.1; HR-MS (EI-TOF): m/z=663.2934,
calcd. for C51H37N (M+): 663.2926.
general procedure; yield: 190 mg (73%). 1H NMR
(400 MHz, CDCl3): d=7.85–7.82 (m, 1H), 7.39–7.29 (m,
6H), 7.28–7.19 (m, 5H), 7.17–7.11 (m, 4H), 7.03 (d, J=
7.6 Hz, 1H), 6.98 (d, J=7.6 Hz, 1H), 6.89–6.83 (m, 2H),
6.80–6.65 (m, 9H), 6.55–6.54 (m, 2H), 6.46 (t, J=7.4 Hz,
1H), 6.13 (t, J=7.4 Hz, 1H), 2.74 (s, 3H); 13C NMR
(100 MHz, CDCl3): d=156.2, 151.1, 140.9, 140.8, 140.2,
139.1, 138.2, 137.8, 137.5, 135.2, 133.5, 133.4, 132.1, 131.6,
131.4, 131.3, 131.2, 131.0, 130.5, 130.3, 129.4, 129.2, 127.6,
127.4, 127.2, 127.1, 126.6, 126.5, 126.4, 126.3, 126.1, 125.9,
125.8, 125.3, 125.2, 125.1, 125.0, 124.7, 124.5, 22.3; HR-MS
(EI-TOF): m/z=649.2770, calcd. for C50H35N (M+):
649.2770.
7-Methoxy-1-methyl-4-phenyl-3-(5,6,7,8-tetraphenylnaph-
thalen-1-yl)isoquinoline (3f): obtained as a white solid ac-
cording to the general procedure; yield: 190 mg (70%).
1H NMR (400 MHz, CDCl3): d=7.88 (s, 1H), 7.45–7.35 (m,
5H), 7.29–7.21 (m, 4H), 7.19–7.13 (m, 4H), 7.03 (d, J=
7.2 Hz, 1H), 6.98 (d, J=7.6 Hz, 1H), 6.92–6.83 (m, 2H),
6.80–6.70 (m, 8H), 6.66 (d, J=6.8 Hz, 1H), 6.57–6.50 (m,
3H), 6.19 (t, J=7.4 Hz, 1H), 2.71 (s, 3H); 13C NMR
(100 MHz, CDCl3): d=156.6, 155.5, 152.9, 141.4, 141.0,
140.8, 140.2, 139.8, 139.2, 138.2, 138.0, 137.9, 133.4, 133.0,
132.5, 131.4, 131.3, 130.9, 130.4, 129.9, 129.2, 127.7, 127.6,
127.3, 126.5, 126.4, 126.2, 125.8, 125.5, 125.4, 125.2, 125.0,
124.8, 124.6, 124.3, 117.8, 109.8, 55.6, 22.9; HR-MS (EI-
TOF): m/z=679.2870, calcd. for C51H37NO (M+): 679.2875.
6-Methoxy-1-methyl-4-phenyl-3-(5,6,7,8-tetraphenylnaph-
thalen-1-yl)isoquinoline (3g): obtained as a white solid ac-
cording to the general procedure; yield: 260 mg (96%).
1H NMR (400 MHz, CDCl3): d=7.82 (d, J=9.2 Hz, 1H),
7.42–7.38 (m, 3H), 7.24–7.19 (m, 3H), 7.18–7.11 (m, 4H),
7.09–7.06 (m, 1H), 7.04–6.99 (m, 3H), 6.91 (t, J=7.4 Hz,
1H), 6.87–6.82 (m, 1H), 6.80–6.78 (m,3H), 6.75–6.67 (m,
7H), 6.57–6.50 (m, 3H), 6,19 (t, J=7.2 Hz, 1H), 3.68 (s,
3H), 2.69 (s, 3H); 13C NMR (100 MHz, CDCl3): d=160.1,
155.5, 152.4, 140.9, 140.8, 140.2, 140.1, 140.0, 139.3, 138.3,
138.1, 137.8, 137.7, 137.2, 133.5, 133.4, 133.3, 132.1, 131.5,
131.2, 131.0, 130.4, 130.1, 128.7, 127.6, 127.5, 127.4, 127.2,
127.1, 127.0, 126.6, 126.5, 126.4, 126.3, 125.8, 125.3, 125.2,
125.0, 124.7, 124.4, 121.5, 118.7, 55.2, 22.2; HR-MS (EI-
TOF): m/z=679.2883, calcd. for C51H37NO (M+): 679.2875.
1-Methyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-yl)-
d4-1-Methyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-
yl)isoquinoline (3b-d4): obtained as a white solid according
to the general procedure; yield: 10 mg (15%). 1H NMR
(400 MHz, CDCl3): d=7.43–7.37 (m, 3H), 7.28–7.20 (m,
4H), 7.18–7.11 (m, 4H), 7.03 (d, J=7.2 Hz, 1H), 6.98 (d, J=
7.6 Hz, 1H), 6.89–6.82 (m, 2H), 6.79–6.65 (m, 9 H), 6.5–6.53
(m, 2H), 6.46 (t, J=7.4 Hz, 1H), 6.12 (t, J=7.4 Hz, 1H),
2,74 (s, 3H).
1,8-Dimethyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-
yl)isoquinoline (3c): obtained as a white solid according to
the general procedure; yield: 60 mg (23%). 1H NMR
(400 MHz, CDCl3): d=7.41–7.39 (m, 2H), 7.35–7.32 (m,
1H), 7.27–7.18 (m, 7H), 7.17–7.10 (m, 4H), 7.02–6.92 (m,
2H), 6.91 (t, J=7.4 Hz, 1H), 6.85–6.83 (m, 1H), 6.77–6.65
(m, 9H), 6.54–6.49 (m, 3H), 6.13 (t, J=7.4H, 1H), 2.89 (s,
3H), 2. 83 (s, 3H); 13C NMR (100 MHz, CDCl3): d=155.9,
151.0, 141.0, 140.9, 140.8, 140.2, 140.1, 138.9, 138.3, 138.2,
138.1, 137.7, 137.2, 135.4, 133.4, 133.3, 132.0, 131.4, 131.3,
131.2, 131.0, 129.5, 129.4, 128.5, 127.6, 127.4, 127.1, 126.8,
126.6, 126.4, 126.3, 125.8, 125.2, 125.0, 124.6, 124.5, 29.3,
25.9; HR-MS (EI-TOF): m/z=663.2930, calcd. for C51H37N
(M+): 663.2926.
1,7-Dimethyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-
yl)isoquinoline (3d): obtained as a white solid according to
the general procedure; yield: 184 mg (69%). 1H NMR
(400 MHz, CDCl3): d=7.66 (s, 1H), 7.42–7.32 (m, 4H),
7.28–7.17 (m, 5H), 7.15–7.10 (m, 4H), 7.03 (d, J=7.6 Hz,
1H), 6.98 (d, J=7.6 Hz, 1H), 6.89–6.82 (m, 2H), 6.79–6.69
(m, 8H), 6.66 (d, J=7.6 Hz, 1H), 6.54 (d, J=6.4 Hz, 1 H),
6.48 (d, J=7.4 Hz, 1H), 6.15 (t, J=7.6 Hz, 1H), 2.71 (s,
3H), 2,50 (s, 3H); 13C NMR (100 MHz, CDCl3): d=155.4,
150.9, 140.9, 140.2, 140.1, 139.2, 139.3, 138.3, 138.2, 137.8,
137.7, 135.8, 133.4, 132.1, 131.4, 131.3, 131.2, 131.1, 130.4,
130.3, 129.1, 127.6, 127.4, 127.0, 126.6, 126.4, 126.2, 125.8,
125.3, 125.2, 125.0, 124.7, 124.5, 124.1, 22.3, 22.0; HR-MS
(EI-TOF): m/z=663.2933, calcd. for C51H37N (M+):
663.2926.
1,6-Dimethyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-
yl)isoquinoline (3e): obtained as a white solid according to
the general procedure; yield: 211 mg (79%). 1H NMR
(400 MHz, CDCl3): d=7.79 (d, J=8.4 Hz, 1H), 7.41–7.37
(m, 3H), 7.28–7.19 (m, 6H), 7.16–7.10 (m, 4H), 7.04–6.98,
(m, 2H), 6.91 (t, J=7.4 Hz, 1H), 6.87–6.82 (m, 1H), 6.79–
6.62 (m, 9H), 6.54–6.48 (m, 3H), 6.13 (t, J=7.4H, 1H), 2.70
AHCTUNGTREGiNNUN soquinolin-6-ol (3h): obtained as a white solid according to
the general procedure; yield: 216 mg (81%). 1H NMR
(400 MHz, CDCl3): d=7.72–7.69 (m, 1H), 7.35–7.31 (m,
2H), 7.22–7.18 (m, 1H), 7.14–7.11 (m, 3H), 7.06–6.91 (m,
8H), 6.85–6.81 (m, 1H), 6.78–6.74 (m, 2H), 6.73–6.64 (m,
6H), 6.59 (s, 1H), 6.53–6.47 (m, 3H), 6.13 (t, J=7.4 Hz,
1H), 2,58 (s, 3H); 13C NMR (100 MHz, CDCl3): d=155.3,
140.8, 140.7, 140.1, 138.4, 138.1, 137.6, 133.4, 133.2, 132.2,
131.4, 131.3, 131.2, 131.1, 131.0, 130.9, 130.5, 129.9, 127.6,
127.5, 127.3, 127.0, 126.6, 126.5, 126.4, 126.3, 126.0, 125.4,
125.3, 125.1, 124.8, 124.3, 107.9, 21.2; HR-MS (EI-TOF):
m/z=665.2720, calcd. for C50H35NO (M+): 665.2719.
N-(1-Methyl-4-phenyl-3-(5,6,7,8-tetraphenylnaphthalen-1-
yl)isoquinolin-6-yl)acetamide (3i): obtained as a yellow solid
according to the general procedure; yield: 200 mg (71%).
1H NMR (400 MHz, CDCl3): d=7.87 (s, 2H), 7.42–7.36 (m,
4H), 7,29 (s, 1H), 7.24–7.20 (m, 4H), 7.16–7.13 (m, 4H),
7.02 (d, J=7.2 Hz, 1H), 6.98 (d, J=Hz, 1H), 6.90–6.82 (m,
2H), 6.79–6.76 (m, 2H), 6.75–6.65 (m, 7H), 6.57–6.37 (m,
4H), 6.16 (t, J=7.4 Hz, 1H), 2.70 (s, 3H), 2.10 (s, 3H);
13C NMR (100 MHz, CDCl3): d=168.5, 155.8, 140.9, 140.8,
140.1, 139.0, 138.2, 137.7, 137.4, 136.0, 133.5, 133.2, 132.0,
131.5, 131.4, 131.3, 131.1, 131.0, 130.5, 130.1, 128.7, 127.6,
127.5, 127.4, 127.3, 127.1, 126.6, 126.5, 126.4, 126.3, 125.8,
125.4, 125.3, 125.0, 124.8, 124.4, 123.0, 119.7, 113.5, 24.8,
Adv. Synth. Catal. 2014, 356, 2688 – 2696
ꢁ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2693